Another "negative" acute lung injury Trial

Critical Care Medicine

Volumn 40, Issue 1, 2012, Pages 315-316

  Han, Seung Hye ^a   Sevransky, Jonathan ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT CYTOKINE;

ACUTE LUNG INJURY; ARTIFICIAL VENTILATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; DRUG EFFECT; EDITORIAL; HUMAN; MACROPHAGE; MONOCYTE; MULTICENTER STUDY (TOPIC); MULTIPLE ORGAN FAILURE; NEUTROPHIL; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY DISTRESS; SEPSIS; TREATMENT DURATION;

ACUTE LUNG INJURY; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; MALE;

EID: 84055189989     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e318232d307     Document Type: Editorial

References (10)

1. National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Wiedemann HP, Wheeler AP, et al: Comparison of two fluidmanagement strategies in acute lung injury. N Engl J Med 2006; 354:2564-2575
2. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network N Engl J Med 2000 342 1301-1308
3. Diaz JV, Brower R, Calfee CS, et al: Therapeutic strategies for severe acute lung injury. Crit Care Med 2010; 38:1644-1650
4. Umoh NJ, Fan E, Mendez-Tellez PA, et al: Patient and intensive care unit organizational factors associated with low tidal volume ventilation in acute lung injury. Crit Care Med 2008; 36:1463-1468
5. Phua J, Badia JR, Adhikari NK, et al: Has mortality from acute respiratory distress syndrome decreased over time?: A systematic review. Am J Respir Crit Care Med 2009; 179:220-227
6. Paine R 3rd, Standiford TJ, Dechert RE, et al: A randomized trial of recombinant human granulocyte-macrophage colony-stimulating factor for patients with acute lung injury. Crit Care Med 2012; 40:90-97
7. Seymour JF, Presneill JJ, Schoch OD, et al: Therapeutic efficacy of granulocyte-macrophage colony-stimulating factor in patients with idiopathic acquired alveolar proteinosis. Am J Respir Crit Care Med 2001; 163:524-531
8. Altman DG, Bland JM: Absence of evidence is not evidence of absence. BMJ 1995; 311: 485
9. Alderson P: Absence of evidence is not evidence of absence. BMJ 2004; 328:476-477
10. Yilmaz M, Keegan MT, Iscimen R, et al: Toward the prevention of acute lung injury: Protocolguided limitation of large tidal volume ventilation and inappropriate transfusion. Crit Care Med 2007; 35:1660-1666; quiz 1667